G. Hoctin-Boes

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.

J. Cuzick, A. Howell, A. Buzdar, 2006, The Lancet. Oncology.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

M Baum, J Cuzick, J F Forbes, 2005, The Lancet.

Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

R. Sylvester, R. Modigliani, É. Lerebours, 1995, Gut.

The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.

J. Dixon, W. Miller, C. Bellamy, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

A new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the Combined Hormonal Agent Trialists Group (CHAT)

R. Sylvester, W. Jonat, L. Mauriac, 1998 .

PP-8-1 Combined estroyen suppression and receptor (ER) blockade by buserelin (LHRH-A) and tamoxifen (TAM) in premenopausal metastatic breast cancer: Preliminary results of a 3-arm randomized study (EORTC 10881)

J. Klijn, M. Piccart, J. Garcia-conde, 1996 .

Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer

A. Harris, J. Schellens, J. Beijnen, 2008, British Journal of Cancer.

Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.

M. Nooij, M. Namer, I. Vergote, 2001, Gynecologic oncology.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

J. Cuzick, A. Howell, J. Forbes, 2005, The Lancet.